Significant rectal and bladder dose reduction via utilization of foley balloon catheters in high-dose-rate tandem and ovoid intracavitary brachytherapy of the uterine cervix

International Journal of Radiation Oncology Biology Physics

Volumn 59, Issue 1, 2004, Pages 174-178

  Eng, Tony Y ^a   Fuller, Clifton D ^a   Cavanaugh, Sean X ^a   Blough, Melissa M ^a   Sadeghi, Amir ^a   Herman, Terence ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Bladder; Brachytherapy; Cervix; Foley balloon catheter

Indexed keywords

COSTS; PATIENT MONITORING; RADIOTHERAPY; STATISTICAL METHODS; TOXICITY; X RAY ANALYSIS;

BLADDER; BRACHYTHERAPY; DOSE REDUCTION; HIGH-DOSE-RATE;

ONCOLOGY;

CONTRAST MEDIUM;

ARTICLE; BALLOON CATHETER; BLADDER; BRACHYTHERAPY; CALCULATION; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; FEMALE; GEOMETRY; HUMAN; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIATION INJURY; RECTUM; STATISTICAL ANALYSIS; TREATMENT PLANNING; UTERINE CERVIX CARCINOMA; VAGINA; X RAY;

BALLOON DILATATION; BRACHYTHERAPY; FEMALE; HUMANS; RADIATION INJURIES; RADIATION PROTECTION; RADIOTHERAPY DOSAGE; RECTUM; URINARY BLADDER;

EID: 16544382663     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2003.09.090     Document Type: Article

References (27)

1. Nori D., Dasari N., Allbright R.M. Gynecologic brachytherapy I Proper incorporation of brachytherapy into the current multimodality management of carcinoma of the cervix. Semin Radiat Oncol. 12:2002;40-52.
2. Orton C.G. High-dose-rate brachytherapy may be radiobiologically superior to low-dose rate due to slow repair of late-responding normal tissue cells. Int J Radiat Oncol Biol Phys. 49:2001;183-189.
3. Bahena J.H., Martinez A., Yan D., et al. Spatial reproducibility of the ring and tandem high-dose rate cervix applicator. Int J Radiat Oncol Biol Phys. 41:1998;13-19.
4. Pham H.T., Chen Y., Rouby E., et al. Changes in high-dose-rate tandem and ovoid applicator positions during treatment in an unfixed brachytherapy system. Radiology. 206:1998;525-531.
5. Elhanafy O.A., Das R.K., Paliwal B.R., et al. Anatomic variation of prescription points and treatment volume with fractionated high-dose rate gynecological brachytherapy. J Appl Clin Med Phys. 3:2002;1-5.
6. Datta N.R., Kumar S., Das K.J., et al. Variations of intracavitary applicator geometry during multiple HDR brachytherapy insertions in carcinoma cervix and its influence on reporting as per ICRU report 38. Radiother Oncol. 60:2001;15-24.
7. Grigsby P.W., Georgiou A., Williamson J.F., et al. Anatomic variation of gynecologic brachytherapy prescription points. Int J Radiat Oncol Biol Phys. 27:1993;725-729.
8. Sarkaria J.N., Petereit D.G., Stitt J.A., et al. A comparison of the efficacy and complication rates of low dose-rate versus high dose-rate brachytherapy in the treatment of uterine cervical carcinoma. Int J Radiat Oncol Biol Phys. 30:1994;75-82.
9. Chen S.W., Liang J.A., Yang S.N., et al. The prediction of late rectal complications following the treatment of uterine cervical cancer by high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys. 47:2000;955-961.
10. Fujikawa K., Miyamoto T., Ihara Y., et al. High incidence of severe urologic complications following radiotherapy for cervical cancer in Japanese women. Gynecol Oncol. 80:2001;21-23.
11. Ohizumi Y., Akiba T., Imamiya S., et al. Vaginal applicators (ovoids) for local control and alleviation of rectal complications of cervical cancers treated by brachytherapy. Tokai J Exp Clin Med. 24:1999;21-27.
12. Senkus-Konefka E., Kobierska A., Jassem J., et al. Influence of brachytherapy applicators geometry on dose distribution in cervical cancer. Strahlenther Onkol. 173:1997;323-329.
13. Rutten R.R., Lawyer A.A., Berner P. Dose variation due to differences in applicator placement used for intracavitary brachytherapy of cervical cancer. Med Dosim. 23:1998;57-63.
14. Senkus-Konefka E., Kobierska A., Jassem J., et al. Patient-related factors determining geometry of intracavitary applicators and pelvic dose distribution during cervical cancer brachytherapy. Int J Radiat Oncol Biol Phys. 37:1997;531-536.
15. Nag S., Chao C., Erickson B., et al. The American Brachytherapy Society recommendations for low-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 52:2002;33-48.
16. International Commission on Radiation Units and Measurements. ICRU Report 38: Dose and volume specification for reporting intracavitary therapy in gynecology. Bethesda, MD: International Commission on Radiation Units and Measurements; 1985.
17. Dawson-Saunders B. Basic and clinical biostatistics. 2nd ed :1994;Appleton and Lange, Norwalk, CT.
18. Tyree W.C., Cardenes H., Randall M., et al. High-dose-rate brachytherapy for vaginal cancer Learning from treatment complications. Int J Gynecol Cancer. 12:2002;27-31.
19. Orton C.G. High and low dose-rate brachytherapy for cervical carcinoma. [Review] Acta Oncol. 37:1998;117-125.
20. Selke P, Roman TN, Souhami L, et al. Treatment results of high dose rate brachytherapy in patients with carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1993;27:803-809.
21. Decker W.E., Erickson B., Albano K., et al. Comparison of traditional low-dose-rate to optimized and nonoptimized high-dose-rate tandem and ovoid dosimetry. Int J Radiat Oncol Biol Phys. 50:2001;561-567.
22. Clark B.G., Souhami L., Roman T.N., et al. The prediction of late rectal complications in patients treated with high dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 38:1997;989-993.
23. Ferrigno R., dos Santos Novaes P.E., Pellizzon A.C., et al. High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications. Int J Radiat Oncol Biol Phys. 50:2001;1123-1135.
24. Uno T., Itami J., Aruga M., et al. High dose rate brachytherapy for carcinoma of the cervix Risk factors for late rectal complications. Int J Radiat Oncol Biol Phys. 40:1998;615-621.
25. Barillot I., Horiot J.C., Maingon P., et al. Impact on treatment outcome and late effects of customized treatment planning in cervix carcinomas Baseline results to compare new strategies. Int J Radiat Oncol Biol Phys. 48:2000;189-200.
26. Noyes W.R., Peters N.E., Thomadsen B.R., et al. Impact of "optimized" treatment planning for tandem and ring, and tandem and ovoids, using high dose rate brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 31:1995;79-86.
27. Cetingoz R., Ataman O.U., Tuncel N., et al. Optimization in high dose rate brachytherapy for utero-vaginal applications. Radiother Oncol. 58:2001;31-36.